Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Advancements in the diagnosis and treatment of prostate cancer are saving more lives

Prostate cancer is the most common type of cancer among men in the United States aside from skin cancer, according to the Centers for Disease Control and Prevention.

8 Sep 2021

Immune cells present in tumors from head and neck cancer patients, study reports

A new study from scientists at Emory Vaccine Center and Winship Cancer Institute of Emory University reports that the immune cells that are the major targets of immune checkpoint inhibitors are present in tumors from head and neck cancer patients.

2 Sep 2021

The tale of mRNA vaccines: Turning calamity into opportunity

In a review paper published in the journal Nature Reviews, researchers from Carnegie Mellon University and the University of Pennsylvania have described the underlying technologies for mRNA vaccines and their future prospects with improved delivery systems and applications in diseases beyond the ongoing COVID-19 pandemic.

31 Aug 2021

Cardiovascular safety of prostate cancer treatments remains unresolved

The relative cardiovascular safety of different types of androgen deprivation therapy (ADT) for prostate cancer remains unresolved after the PRONOUNCE trial was terminated early. The late breaking research is presented in a Hot Line session today at ESC Congress 2021.

30 Aug 2021

Study provides important insights into prostate cancer metabolism

South Australian medical researchers have identified a new way in which prostate cancer cells use glucose to grow and survive, which in turn could be the secret to destroying them.

27 Aug 2021

Study unravels widespread tumor suppression mechanism that halts cancer metastasis

According to a study by The Wistar Institute, the tumor suppressor Parkin, whose levels are reduced in different cancer types, causes acute metabolic and oxidative stress, suppresses mitochondrial trafficking, and blocks tumor cell movement, reducing primary and metastatic tumor growth.

26 Aug 2021

Intestinal microorganisms help regulate anti-tumor immune responses to radiation therapy, study finds

Cedars-Sinai Cancer researchers have discovered that intestinal microorganisms help regulate anti-tumor immune responses to radiation treatments, and that fungi and bacteria have opposing effects on those responses.

24 Aug 2021

Does SARS-CoV-2 affect male fertility?

A recently published review describes the state of current knowledge regarding the impact of SARS-CoV-2 on the male reproductive system.

23 Aug 2021

Study provides new data on discontinuation of active surveillance by low-risk prostate cancer patients

Nearly half of men initially managed with active surveillance for "low-risk" prostate cancer transition to definitive treatment – such as surgery or radiation therapy – within a few years after diagnosis.

23 Aug 2021

Researchers identify genes associated with biochemical recurrence in prostate adenocarcinoma

Aging-US published "Identification of microenvironment related potential biomarkers of biochemical recurrence at 3 years after prostatectomy in prostate adenocarcinoma" which reported that the authors aimed to identify the potential prognostic genes in the prostate adenocarcinoma microenvironment and to estimate the causal effects simultaneously.

20 Aug 2021

Prostate cancer survivors have persistent fear of cancer recurrence, study reveals

A recent study reveals that some prostate cancer survivors have a persistent fear of cancer recurrence even many years after diagnosis and treatment.

19 Aug 2021

Patients with enlarged prostate may have lower chances of significant prostate cancer

A team of Beaumont Health researchers from Radiology, Radiation Oncology and Urology studied the relationship between benign prostatic hyperplasia, or BPH, and prostate cancer in 405 men by quantitatively looking at different parts of prostate tissue on MRI.

18 Aug 2021

Novel blood test as adjunct to MRI improves prostate cancer screening

Researchers at Karolinska Institutet in Sweden recently reported that magnetic resonance imaging (MRI) could reduce overdiagnoses and thereby improve prostate cancer screening.

12 Aug 2021

Widowhood associated with greater risk of advanced prostate cancer

Social environment is a key factor in the risk of developing prostate cancer. PhD student Charlotte Salmon and Professor Marie-Élise Parent of Institut national de la recherche scientifique (INRS) have shown that widowers are more likely to be diagnosed with advanced prostate cancer.

12 Aug 2021

Many men with prostate cancer may be making treatment choices without understanding all options

One of the bi-products of the COVID-19 pandemic has been a decrease in the number of patients seeing or talking to their GPs, as findings from a Institute of Fiscal Studies report identified late last year.

6 Aug 2021

Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy

The Republic of Belarus Ministry of Health has approved expanding the ongoing clinical trial of CureLab Oncology's Elenagen, an experimental DNA therapy, to include two new arms: 1) hormone-resistant breast cancer; and 2) hormone-resistant metastatic prostate cancer.

3 Aug 2021

Study reveals effective strategy to extend the benefit of immunotherapy for prostate cancer

It's a scientific riddle tangled up in a complex web. How do you turn an immune cold cancer into one that responds to immunotherapy?

2 Aug 2021

Genomic test may help identify prostate cancer patients at high risk of disease progression

After a biopsy comes back positive for prostate cancer, patients and their doctors are often left with a choice between taking a watch-and-wait approach, known as active surveillance, or proceeding with surgery or radiation.

27 Jul 2021

New radiotracer opens the door for advancement of iron-targeted cancer therapies

A new radiotracer that detects iron in cancer cells has proven effective, opening the door for the advancement of iron-targeted therapies for cancer patients.

23 Jul 2021

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

RedHill Biopharma Ltd., a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). Top-line results are expected in the coming weeks.

20 Jul 2021

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Advancements in the diagnosis and treatment of prostate cancer are saving more lives

Immune cells present in tumors from head and neck cancer patients, study reports

The tale of mRNA vaccines: Turning calamity into opportunity

Cardiovascular safety of prostate cancer treatments remains unresolved

Study provides important insights into prostate cancer metabolism

Study unravels widespread tumor suppression mechanism that halts cancer metastasis

Intestinal microorganisms help regulate anti-tumor immune responses to radiation therapy, study finds

Does SARS-CoV-2 affect male fertility?

Study provides new data on discontinuation of active surveillance by low-risk prostate cancer patients

Researchers identify genes associated with biochemical recurrence in prostate adenocarcinoma

Prostate cancer survivors have persistent fear of cancer recurrence, study reveals

Patients with enlarged prostate may have lower chances of significant prostate cancer

Novel blood test as adjunct to MRI improves prostate cancer screening

Widowhood associated with greater risk of advanced prostate cancer

Many men with prostate cancer may be making treatment choices without understanding all options

Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy

Study reveals effective strategy to extend the benefit of immunotherapy for prostate cancer

Genomic test may help identify prostate cancer patients at high risk of disease progression

New radiotracer opens the door for advancement of iron-targeted cancer therapies

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

What to know about prostate cancer eBook

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Newsletters you may be interested in